8-K: Centrus Launches Commercial LEU Enrichment Manufacturing

Centrus Energy has commenced domestic centrifuge manufacturing to support a multi-billion-dollar uranium enrichment expansion, aiming to meet a $2.3 billion sales backlog and create thousands of U.S. jobs.

Summary

• Centrus Energy has initiated domestic centrifuge manufacturing to support commercial Low-Enriched Uranium (LEU) enrichment activities at its Piketon, Ohio, facility.
• The company plans a multi-billion-dollar uranium enrichment expansion to fulfill a growing backlog of $2.3 billion in contingent LEU sales under U.S. and international customer contracts.
• Centrus is also targeting future commercial-scale production of High-Assay, Low-Enriched Uranium (HALEU).
• The project is expected to create 1,000 construction jobs and 300 new operations jobs in Ohio, retain 150 existing jobs, add hundreds of direct jobs in Tennessee, and thousands of indirect jobs nationwide.
• New enrichment capacity is expected to come online in 2029.

Sentiment

Score: 9

Explanation: The announcement details the commencement of a critical domestic manufacturing initiative, backed by substantial existing and potential funding, significant customer contracts, and a clear strategic vision to address U.S. energy and national security needs. The project is expected to create thousands of jobs and re-establish U.S. leadership in uranium enrichment.

Positives

• Commencement of domestic centrifuge manufacturing marks a significant step towards U.S. energy independence in uranium enrichment.
• A substantial backlog of $2.3 billion in contingent LEU sales contracts provides a strong revenue pipeline.
• Targeting future commercial-scale HALEU production positions Centrus for growth in advanced nuclear fuel markets.
• The project is expected to create thousands of American jobs, including 1,000 construction jobs, 300 new operations jobs, and hundreds of direct manufacturing jobs.
• Strong financial backing includes $1.2 billion raised via convertible notes, a cash balance of over $1.6 billion as of September 30, 2025, and a launched $1 billion at-the-market offering.
• Centrus is a finalist for Department of Energy task orders for LEU and HALEU production, potentially worth ~$900 million per task order.
• A proposed partnership with Korea Hydro & Nuclear Power (KHNP) and POSCO International indicates potential for direct foreign investment.
• Centrus's AC100M centrifuge is the only U.S.-origin enrichment technology deployment-ready for national security missions, with the NNSA expressing intent to contract.

Negatives

• The $2.3 billion in customer contracts are contingent upon Centrus realizing certain milestones towards building new capacity, introducing execution risk.
• New enrichment capacity is not expected to come online until 2029, indicating a long lead time for revenue generation from this expansion.
• The $1 billion at-the-market offering could lead to share dilution.

Risks

• Geopolitical conflicts, including the war in Ukraine, could impact operations.
• Market demand and competition could affect sales and profitability.
• Changes in economic or industry conditions may negatively influence business.
• Supply chain disruptions could hinder manufacturing and project timelines.
• Imposition of tariffs and/or sanctions could impact the ability to obtain, deliver, transport, or sell LEU or its components.
• Regulatory approvals and compliance requirements pose potential hurdles.
• Department of Energy procurement decisions and U.S. government appropriations are critical for funding.
• Government decisions regarding the lease with the DOE in Piketon, Ohio, including term and scope of permitted activities, could impact the project.
• Ability to attract qualified employees necessary for the potential expansion in Oak Ridge, Tennessee, or Piketon, Ohio, is crucial.
• Ability to execute strategic initiatives successfully is not guaranteed.

Future Outlook

Centrus expects to leverage its multi-billion-dollar uranium enrichment expansion to meet its growing backlog of $2.3 billion in contingent LEU sales and targets future commercial-scale production of High-Assay, Low-Enriched Uranium (HALEU). The first new production capacity is anticipated to come online in 2029, with the project creating thousands of jobs and supporting U.S. energy and national security needs amidst growing demand for nuclear power and the impending ban on Russian enriched uranium imports.

Management Comments

• "We are excited to announce the official commencement of our industrial-scale centrifuge manufacturing build for commercial LEU enrichment."
• "We make this announcement after carefully evaluating the business internal and external progress as well as its future prospects and many competitive advantages."
• "This historic step demonstrates Centrus commitment to meeting our growing backlog of contingent commercial LEU customer contracts."
• "Reclaiming American nuclear leadership on the global will catalyze additional private investment and enable further expansion as the market continues to grow."
• "Uranium enrichment in Ohio has a big future, and this is just the beginning."

Industry Context

The announcement positions Centrus to reclaim American nuclear leadership, addressing the urgent need for domestic, U.S.-owned uranium enrichment capacity. This is critical given that the last U.S.-owned large-scale plant shut down in 2013, leaving the U.S. dependent on foreign, state-owned enterprises for nearly 100% of global uranium enrichment. The demand for nuclear power is expected to grow, and the complete ban on Russian enriched uranium imports starting in 2028 further underscores the strategic importance and high demand for new domestic capacity.

Comparison to Industry Standards

• The U.S. has been almost 100% dependent on foreign, state-owned enterprises for uranium enrichment since the last U.S.-owned large-scale plant shut down in 2013, making Centrus's initiative a critical step towards re-establishing domestic capacity.
• The impending ban on Russian enriched uranium imports starting in 2028 creates a significant market void that Centrus aims to fill, contrasting with the current reliance on international suppliers like TENEX (Russia).
• Centrus's AC100M centrifuge technology is highlighted as the only U.S.-origin enrichment technology that is deployment-ready for national security missions, distinguishing it from foreign technologies used by competitors.
• The multi-billion-dollar expansion and $2.3 billion in contingent contracts indicate a scale of investment and market capture comparable to major global players in the nuclear fuel cycle, though specific competitor names or project sizes are not detailed for direct comparison.

Stakeholder Impact

• Shareholders: Potential for long-term value creation through strategic expansion, significant contracts, and re-establishment of U.S. nuclear leadership. Potential dilution from the $1 billion at-the-market offering.
• Employees: Creation of 1,000 construction jobs, 300 new operations jobs in Ohio, retention of 150 existing jobs, and hundreds of new direct jobs in Tennessee, along with thousands of indirect jobs.
• Customers: Assurance of a domestic, reliable supply of LEU and future HALEU, reducing dependence on foreign sources.
• U.S. Government/National Security: Enhanced energy security and national security through domestic uranium enrichment capabilities, fulfilling critical missions.
• Local Communities (Ohio, Tennessee): Significant economic boost through job creation and investment in manufacturing facilities.

Next Steps

• Continue manufacturing centrifuges at the Oak Ridge, Tennessee factory.
• Continue expanding manufacturing capacity in Tennessee.
• Continue hiring in Tennessee and Ohio to support the project.
• Bring the first new production capacity online in 2029.
• Pursue additional LEU and HALEU sales opportunities.
• Maximize efforts in direct foreign investment with Korea and other nations.

Key Dates

Recommendation

This filing signals a pivotal moment for Centrus Energy, marking the commencement of a multi-billion-dollar domestic uranium enrichment expansion. The company is strategically positioned to capitalize on a growing market, driven by increasing demand for nuclear power and the impending ban on Russian enriched uranium. With a substantial $2.3 billion backlog in contingent sales, significant capital secured and in progress (including potential DOE funding), and a clear path to re-establish U.S. leadership in a critical industry, the long-term growth prospects are compelling. The creation of thousands of jobs and the national security implications further strengthen the investment thesis, making Centrus a strong buy for investors seeking exposure to the revitalized nuclear energy sector and U.S. energy independence.

Keywords

Uranium Enrichment, LEU, HALEU, Centrifuge Manufacturing, Nuclear Fuel, Energy Security, Piketon Ohio, Centrus Energy, DOE Funding, Advanced Manufacturing